Mission Statement: Our goal is to use cell therapies and related products to improve the quality of life of patients suffering from immune disorders.


Patients with acute and chronic immune disorders have an increased risk of death and a reduced quality of life. To make matters worse, current pharmaceutical options can have toxic side effects and put patients at risk for life-threatening infections. This means that physicians are not only managing their patients’ illnesses but are also constantly worried about whether their treatment regimen is doing more help than harm.

Mesenchymal stromal cells (MSCs) show promise for effectively treating immune disorders, and in clinical trials conducted by others, they have shown few side effects. Our hope is that our EMC therapy – IMMPERA – will provide an effective AND safe solution, allowing patients to return to a lifestyle closer to before their onset of disease.